Evidence map›Paper›PMID 33211746›Full record

ArticlePloS one2020

In utero exposure to protease inhibitor-based antiretroviral regimens delays growth and developmental milestones in mice.

Ambalika Sarkar, Kayode Balogun, Monica S Guzman Lenis, Sebastian Acosta, Howard T Mount, Lena Serghides

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.1field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Ambalika SarkarToronto General Hospital Research Institute, University Health Network, Toronto, Ontario, Canada.
Kayode BalogunToronto General Hospital Research Institute, University Health Network, Toronto, Ontario, Canada.
Monica S Guzman LenisToronto General Hospital Research Institute, University Health Network, Toronto, Ontario, Canada.
Sebastian AcostaToronto General Hospital Research Institute, University Health Network, Toronto, Ontario, Canada.
Howard T MountDepartments of Psychiatry & Physiology, Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, Ontario, Canada.ORCID 0000-0003-4666-0242
Lena SerghidesToronto General Hospital Research Institute, University Health Network, Toronto, Ontario, Canada.ORCID 0000-0002-2817-6134
University Health Network · CAUniversity of Toronto · CA

Funding

CIHR
6 · The paper itself

Abstract

Antiretroviral therapy (ART) in pregnancy has dramatically reduced HIV vertical transmission rates. Consequently, there is a growing number of children that are HIV exposed uninfected (CHEUs). Studies suggest that CHEUs exposed in utero to ART may experience developmental delays compared to their peers. We investigated the effects of in utero ART exposure on perinatal neurodevelopment in mice, through assessment of developmental milestones. Developmental milestone tests (parallel to reflex testing in human infants) are reflective of brain maturity and useful in predicting later behavioral outcomes. We hypothesized that ART in pregnancy alters the in utero environment and thereby alters developmental milestone outcomes in pups. Throughout pregnancy, dams were treated with boosted-atazanavir combined with either abacavir/lamivudine (ATV/r/ABC/3TC), or tenofovir/emtricitabine (ATV/r/TDF/FTC), or water as control. Pups were assessed daily for general somatic growth and on a battery of tests for primitive reflexes including surface-righting, negative-geotaxis, cliff-aversion, rooting, ear-twitch, auditory-reflex, forelimb-grasp, air-righting, behaviors in the neonatal open field, and olfactory test. In utero exposure to either ART regimen delayed somatic growth in offspring and evoked significant delays in the development of negative geotaxis, cliff-aversion, and ear-twitch reflexes. Exposure to ATV/r/ABC/3TC was also associated with olfactory deficits in male and forelimb grasp deficits in female pups. To explore whether delays persisted into adulthood we assessed performance in the open field test. We observed no significant differences between treatment arm for males. In females, ATV/r/TDF/FTC exposure was associated with lower total distance travelled and less ambulatory time in the centre, while ATV/r/ABC/3TC exposure was associated with higher resting times compared to controls. In utero PI-based ART exposure delays the appearance of primitive reflexes that involve vestibular and sensory-motor pathways in a mouse model. Our findings suggest that ART could be disrupting the normal progress/maturation of the underlying neurocircuits and encourage further investigation for underlying mechanisms.

Indexed as

Prenatal Exposure Delayed EffectsAbacavirAnimalsAnti-HIV AgentsAtazanavir SulfateDevelopmental DisabilitiesDideoxynucleosidesEmtricitabineExploratory BehaviorFemaleFetal Growth RetardationGrowth DisordersHand StrengthHIV Protease InhibitorsHoming BehaviorLamivudineAbacavirAnti-HIV AgentsAtazanavir SulfateDideoxynucleosidesEmtricitabineHIV Protease InhibitorsLamivudineTenofovir

Identifiers

PMID33211746
PMCPMC7676697
OpenAlexW3105689204

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.